Trimethoprim-sulfamethoxazole treatment for meningitis owing to multidrug-resistant Elizabethkingia meningoseptica in an extremely low-birthweight, premature infant


Creative Commons License

Gokce I. K. , ONCEL M. Y. , Ozdemir R. , ERDEVE O., OGUZ S. S. , CANPOLAT F. E. , ...Daha Fazla

PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, cilt.32, ss.177-179, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 32 Konu: 3
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1179/2046905511y.0000000008
  • Dergi Adı: PAEDIATRICS AND INTERNATIONAL CHILD HEALTH
  • Sayfa Sayıları: ss.177-179

Özet

Elizabethkingia meningoseptica is a recognised cause of meningitis in premature neonates and severe infections in immunocompromised adults; multi-drug resistance is a major issue. A premature infant developed sepsis, meningitis and hydrocephalus owing to E. meningoseptica and was treated successfully with trimethoprim-sulfamethoxazole (TMP-SMZ) for 3 weeks. A ventriculoperitoneal shunt was required for hydrocephalus. This is the youngest patient with meningitis caused by E. meningoseptica to have responded to TMP-SMZ.